Boenning & Scattergood, Inc. Amgen Inc Transaction History

Boenning & Scattergood, Inc.

$622 Million
Q4 2022

A detailed history of Boenning & Scattergood, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Boenning & Scattergood, Inc. holds 7,064 shares of AMGN stock, worth $1.87 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

7,064

Previous 6,959 1.51%

Holding current value

$1.87 Million

Previous $1.57 Million 8.86%

% of portfolio

0.27%

Previous 0.32%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $24,048 - $30,556	105 Added 1.51%	7,064 $1.71 Million
Q3 2022 Oct 11, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 0.01%	6,959 $1.57 Million
Q2 2022 Jul 13, 2022	SELL	$230.71 - $256.74 $24,455 - $27,214	-106 Reduced 1.5%	6,958 $1.69 Million
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $5,262 - $5,821	-24 Reduced 0.34%	7,064 $1.71 Million
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $5,767 - $6,600	-29 Reduced 0.41%	7,088 $1.6 Million
Q3 2021 Oct 21, 2021	SELL	$212.27 - $248.7 $10,401 - $12,186	-49 Reduced 0.68%	7,117 $1.51 Million
Q2 2021 Jul 21, 2021	BUY	$233.58 - $259.14 $16,584 - $18,398	71 Added 1.0%	7,166 $1.75 Million
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $116,946 - $136,282	527 Added 8.02%	7,095 $1.77 Million
Q4 2020 Jan 20, 2021	BUY	$216.38 - $257.67 $43,059 - $51,276	199 Added 3.12%	6,568 $1.51 Million
Q3 2020 Oct 21, 2020	BUY	$234.65 - $260.95 $85,647 - $95,246	365 Added 6.08%	6,369 $1.62 Million
Q2 2020 Jul 14, 2020	BUY	$197.81 - $242.74 $159,434 - $195,648	806 Added 15.51%	6,004 $1.42 Million
Q1 2020 Apr 13, 2020	BUY	$182.24 - $241.7 $22,780 - $30,212	125 Added 2.46%	5,198 $1.05 Million
Q4 2019 Jan 15, 2020	BUY	$189.21 - $243.2 $13,244 - $17,024	70 Added 1.4%	5,073 $1.22 Million
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $21,763 - $26,077	125 Added 2.56%	5,003 $968,000
Q2 2019 Jul 15, 2019	SELL	$166.7 - $195.41 $33,340 - $39,082	-200 Reduced 3.94%	4,878 $899,000
Q1 2019 Apr 22, 2019	BUY	$180.87 - $203.88 $36,174 - $40,776	200 Added 4.1%	5,078 $965,000
Q4 2018 Jan 22, 2019	BUY	$178.4 - $208.25 $53,520 - $62,475	300 Added 6.55%	4,878 $950,000
Q3 2018 Oct 05, 2018	BUY	$185.29 - $208.89 $22,234 - $25,066	120 Added 2.69%	4,578 $949,000
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $740,250 - $831,461	4,458 New	4,458 $823,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boenning & Scattergood, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boenning & Scattergood, Inc. with notifications on news.

Account

Boenning & Scattergood, Inc. Amgen Inc Transaction History